New Strategies Targeting Cancer Metabolism: Anticancer Drugs, Synthetic Analogues and Antitumor Agents

★★★★★ 4.3 70 reviews

US$58.85
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by kyttarometria.gr
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$58.85
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 27
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by kyttarometria.gr
Free 30-day returns Details

Product details

Management number 233567249 Release Date 2026/06/27 List Price US$58.85 Model Number 233567249
Category

New Strategies Targeting Cancer Metabolism: Anticancer Drugs, Synthetic Analogues and Antitumor Agents presents up-to-date synthetic strategies for three categories of antimetabolites: antifolates, purines and pyrimidines, the main classes of antimetabolites which are integrated into various pharmaceutical agents. Many of these antimetabolites are considered potent chemotherapeutic agents which have great potential impact on medical research. These main classes of antimetabolites are used in the treatment of critical diseases including cancer, malignancies, autoimmune diseases, and many other non-malignant diseases. Antineoplastic drugs such as alkylating agents which have significant effects are described. Novel synthetic strategies for many anticancer alkylating agents including nitrogen mustards, chlorambucil, melphalan, ifosamide, oxaliplatin and temozolomide are explored. Natural products have offered some of the most significant drugs for treating cancer, as many drugs currently in clinical use are derived from natural products as camptothecins, vinca alkaloids, and derivatives of podophyllotoxin. They provide a contribution that is essential for modern drug discovery and development. In this book, insights into a broad array of novel compounds are reviewed, well-recognized synthetic approaches are emphasized for further anticancer drug development and discovery, and the biological evaluation of novel synthesized compounds are included. This comprehensive reference is a valuable resource for medical chemists working in drug discovery and development, as well as pharmacologists and biochemists working in related fields.Provides the only resource dedicated to synthetic strategies of antimetabolitesFeatures synthetic strategies for nucleosides and their analoguesIncludes coverage of purine-, pyrimidine- and antifolate-based anticancer drugsThe most significant anticancer alkylating agents and natural products are demonstrated Read more

ISBN10 0128217839
ISBN13 978-0128217832
Edition 1st
Language English
Publisher Elsevier
Dimensions 5.98 x 1.42 x 9.02 inches
Item Weight 2.18 pounds
Print length 628 pages
Publication date June 21, 2022

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.3 out of 5
★★★★★
70 ratings | 29 reviews
How item rating is calculated
View all reviews
5 stars
80% (56)
4 stars
6% (4)
3 stars
3% (2)
2 stars
1% (1)
1 star
10% (7)
Sort by

There are currently no written reviews for this product.